George Bensch

2.5k total citations
32 papers, 1.6k citations indexed

About

George Bensch is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology and Allergy. According to data from OpenAlex, George Bensch has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Physiology, 21 papers in Pulmonary and Respiratory Medicine and 7 papers in Immunology and Allergy. Recurrent topics in George Bensch's work include Asthma and respiratory diseases (25 papers), Respiratory and Cough-Related Research (16 papers) and Inhalation and Respiratory Drug Delivery (14 papers). George Bensch is often cited by papers focused on Asthma and respiratory diseases (25 papers), Respiratory and Cough-Related Research (16 papers) and Inhalation and Respiratory Drug Delivery (14 papers). George Bensch collaborates with scholars based in United States, Switzerland and Germany. George Bensch's co-authors include Harold S. Nelson, Jonathan Corren, William W. Busse, James B. Whitmore, Larry Borish, Jan M. Agosti, Gregg J. Berdy, Dennis L. Spangler, John M. Fahrenholz and Yun Chon and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Journal of Allergy and Clinical Immunology.

In The Last Decade

George Bensch

31 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
George Bensch United States	19	1.2k	863	443	322	133	32	1.6k
M.R. Sears New Zealand	11	1.7k 1.4×	1.3k 1.5×	415 0.9×	162 0.5×	50 0.4×	13	2.0k
Paul Rafferty United Kingdom	23	931 0.8×	724 0.8×	342 0.8×	182 0.6×	61 0.5×	50	1.5k
Craig LaForce United States	31	2.9k 2.4×	2.0k 2.3×	1.4k 3.1×	183 0.6×	82 0.6×	110	3.4k
Andre van As United States	15	1.7k 1.4×	1.3k 1.5×	678 1.5×	223 0.7×	24 0.2×	22	2.0k
N. G. M. Orie Netherlands	18	922 0.8×	797 0.9×	349 0.8×	124 0.4×	76 0.6×	69	1.5k
Pedro Giavina‐Bianchi Brazil	22	936 0.8×	608 0.7×	603 1.4×	399 1.2×	57 0.4×	136	2.0k
Inseon S. Choi South Korea	21	900 0.7×	430 0.5×	251 0.6×	330 1.0×	42 0.3×	98	1.4k
Els J.M. Weersink Netherlands	24	1.2k 1.0×	1.2k 1.3×	257 0.6×	208 0.6×	85 0.6×	65	1.7k
Lyndon E. Mansfield United States	22	971 0.8×	522 0.6×	771 1.7×	216 0.7×	42 0.3×	87	1.8k
Anon Jatakanon United Kingdom	13	2.4k 1.9×	2.1k 2.4×	305 0.7×	381 1.2×	72 0.5×	14	2.9k

Countries citing papers authored by George Bensch

Since Specialization

Citations

This map shows the geographic impact of George Bensch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by George Bensch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites George Bensch more than expected).

Fields of papers citing papers by George Bensch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by George Bensch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by George Bensch. The network helps show where George Bensch may publish in the future.

Co-authorship network of co-authors of George Bensch

This figure shows the co-authorship network connecting the top 25 collaborators of George Bensch. A scholar is included among the top collaborators of George Bensch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with George Bensch. George Bensch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kerwin, Edward, et al.. (2020). A Dose-Ranging Study of Epinephrine Hydrofluroalkane Metered-Dose Inhaler (Primatene ^® MIST) in Subjects with Intermittent or Mild-to-Moderate Persistent Asthma. Journal of Aerosol Medicine and Pulmonary Drug Delivery. 33(4). 186–193. 2 indexed citations

Bensch, George, Leon S. Greos, Sandra M. Gawchik, Euloge Kpamegan, & Ken B. Newman. (2011). Linear growth and bone maturation are unaffected by 1 year of therapy with inhaled flunisolide hydrofluoroalkane in prepubescent children with mild persistent asthma: A randomized, double-blind, placebo-controlled trial. Annals of Allergy Asthma & Immunology. 107(4). 323–329. 16 indexed citations

Corren, Jonathan, William W. Busse, Eli O. Meltzer, et al.. (2010). A Randomized, Controlled, Phase 2 Study of AMG 317, an IL-4Rα Antagonist, in Patients with Asthma. American Journal of Respiratory and Critical Care Medicine. 181(8). 788–796. 228 indexed citations

Whalen, K., Holly Legault, Andrew Hill, et al.. (2008). In vitroallergen challenge of peripheral blood induces differential gene expression in mononuclear cells of asthmatic patients: inhibition of cytosolic phospholipase A_2αovercomes the asthma‐associated response. Clinical & Experimental Allergy. 38(10). 1590–1605. 12 indexed citations

Mah, Francis S., et al.. (2007). Efficacy and comfort of olopatadine 0.2% versus epinastine 0.05% ophthalmic solution for treating itching and redness induced by conjunctival allergen challenge. Current Medical Research and Opinion. 23(6). 1445–1452. 20 indexed citations

Bensch, George, Bruce M. Prenner, Robert Berkowitz, et al.. (2006). Once-daily evening administration of mometasone furoate in asthma treatment initiation. Annals of Allergy Asthma & Immunology. 96(4). 533–540. 28 indexed citations

Welch, Michael J., Harold S. Nelson, Gail Shapiro, et al.. (2004). Comparison of Patient Preference and Ease of Teaching Inhaler Technique for Pulmicort Turbuhaler ^® versus Pressurized Metered-Dose Inhalers. Journal of Aerosol Medicine. 17(2). 129–139. 46 indexed citations

Bensch, George & Bruce M. Prenner. (2003). Combination Therapy: Appropriate for Everyone?. Journal of Asthma. 40(4). 431–444. 3 indexed citations

Buhl, Roland, G. Hanf, M. Solèr, et al.. (2002). The anti-IgE antibody omalizumab improves asthma-related quality of life in patients with allergic asthma. European Respiratory Journal. 20(5). 1088–1094. 124 indexed citations

10.

Redding, Gregory J., Robert Walker, Colin Hessel, et al.. (2002). Safety and tolerability of cold-adapted influenza virus vaccine in children and adolescents with asthma. The Pediatric Infectious Disease Journal. 21(1). 44–48. 57 indexed citations

11.

Leonardi, Andrea, et al.. (2002). Randomized, double-masked, placebo-controlled comparison of the efficacy of emedastine difumarate 0.05% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the human conjunctival allergen challenge model. Clinical Therapeutics. 24(3). 409–416. 23 indexed citations

12.

Borish, Larry, Harold S. Nelson, Jonathan Corren, et al.. (2001). Efficacy of soluble IL-4 receptor for the treatment of adults with asthma. Journal of Allergy and Clinical Immunology. 107(6). 963–970. 301 indexed citations

13.

Noonan, Michael, Jill P. Karpel, George Bensch, et al.. (2001). Comparison of once-daily to twice-daily treatment with mometasone furoate dry powder inhaler. Annals of Allergy Asthma & Immunology. 86(1). 36–43. 78 indexed citations

14.

Bensch, George, et al.. (2001). A randomized, 12-week, double-blind, placebo-controlled study comparing formoterol dry powder inhaler with albuterol metered-dose inhaler. Annals of Allergy Asthma & Immunology. 86(1). 19–27. 56 indexed citations

15.

Spangler, Dennis L., George Bensch, & Gregg J. Berdy. (2001). Evaluation of the efficacy of olapatadine hydrochloride 0.1% ophthalmic solution and azelastine hydrochloride 0.05% ophthalmic solution in the conjunctival allergen challenge model. Clinical Therapeutics. 23(8). 1272–1280. 46 indexed citations

16.

Milgrom, Henry, et al.. (2001). Low-dose levalbuterol in children with asthma: Safety and efficacy in comparison with placebo and racemic albuterol. Journal of Allergy and Clinical Immunology. 108(6). 938–945. 85 indexed citations

17.

Corren, Jonathan, Harold S. Nelson, Leon S. Greos, et al.. (2001). Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients. Annals of Allergy Asthma & Immunology. 87(5). 405–411. 40 indexed citations

18.

Berdy, Gregg J., et al.. (2000). A comparison of the relative efficacy and clinical performance of olopatadine hydrochloride 0.1% ophthalmic solution and ketotifen fumarate 0.025% ophthalmic solution in the conjunctival antigen challenge model. Clinical Therapeutics. 22(7). 826–833. 63 indexed citations

19.

DeAbate, C. Andrew, Dan Henry, George Bensch, et al.. (1998). Sparfloxacin vs Ofloxacin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis. CHEST Journal. 114(1). 120–130. 52 indexed citations

20.

Nelson, Harold S., George Bensch, Warren Pleskow, et al.. (1998). Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma☆☆☆★★★. Journal of Allergy and Clinical Immunology. 102(6). 943–952. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact